![ALS Association Calls on FDA To Follow the Lead Of Canadian and European Counterparts in Expediting Access To Promising New Treatment | The ALS Association ALS Association Calls on FDA To Follow the Lead Of Canadian and European Counterparts in Expediting Access To Promising New Treatment | The ALS Association](https://www.als.org/sites/default/files/2021-04/Amylyx_Paths-to-Access_0421_hero.jpg)
ALS Association Calls on FDA To Follow the Lead Of Canadian and European Counterparts in Expediting Access To Promising New Treatment | The ALS Association
![Parkinson's drug helps treat ALS, trial using iPS cells discovers | The Asahi Shimbun: Breaking News, Japan News and Analysis Parkinson's drug helps treat ALS, trial using iPS cells discovers | The Asahi Shimbun: Breaking News, Japan News and Analysis](https://p.potaufeu.asahi.com/bcef-p/picture/26139895/475723a548ef615744824902a6ab2790.jpg)
Parkinson's drug helps treat ALS, trial using iPS cells discovers | The Asahi Shimbun: Breaking News, Japan News and Analysis
![ALS News today on X: "A friend recently asked a patient in our forums if his ALS medications are working for him — only he's not sure if it's truly possible to ALS News today on X: "A friend recently asked a patient in our forums if his ALS medications are working for him — only he's not sure if it's truly possible to](https://pbs.twimg.com/media/GKCIv14XcAAL_0O.jpg:large)
ALS News today on X: "A friend recently asked a patient in our forums if his ALS medications are working for him — only he's not sure if it's truly possible to
![GENUV to commence P1/2a Clinical Trial for ALS Drug which Shows Efficacy in Neurogenesis and Neural Homeostasis Recovery GENUV to commence P1/2a Clinical Trial for ALS Drug which Shows Efficacy in Neurogenesis and Neural Homeostasis Recovery](http://img.etoday.co.kr/pto_db/2020/04/600/20200417152523_1450036_650_315.jpg)
GENUV to commence P1/2a Clinical Trial for ALS Drug which Shows Efficacy in Neurogenesis and Neural Homeostasis Recovery
![Amylyx Pharmaceuticals to pull ALS drug Relyvrio from US market in voluntary recall after study showed patients didn't benefit - ABC7 Chicago Amylyx Pharmaceuticals to pull ALS drug Relyvrio from US market in voluntary recall after study showed patients didn't benefit - ABC7 Chicago](https://cdn.abcotvs.com/dip/images/12280786_AP22273019019273.jpg)